Skip to main content
Equibles

Beacon Pointe Advisors, LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1744317 NEWPORT BEACH, CA
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$60,049
-$10,561 QoQ
Shares Held
23,185
+0.8% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 179 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Beacon Pointe Advisors, LLC holds $41,283,927 across 27 Biotechnology names. AVXL ranks #21 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 19,460 $12,134,088
2 INCY
Incyte Corp
 84,502 $9,579,146
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 17,047 $8,467,756
4 NUVB
Nuvation Bio Inc.
 632,251 $3,591,185
5 SMMT
Summit Therapeutics Inc.
 98,114 $1,429,520
6 BNTX
BioNTech SE
 13,199 $1,228,166
7 IBRX
ImmunityBio, Inc.
 73,497 $643,466
8 CRSP
CRISPR Therapeutics AG
 11,307 $616,683

All Filings in AVXL

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,049 23,185
2026-03-31 $70,610 23,000
2025-12-31 $81,880 23,000
2025-09-30 $204,700 23,000
2025-06-30 $212,060 23,000
2025-03-31 $197,340 23,000
2024-12-31 $247,020 23,000
2024-09-30 $130,640 23,000
2024-06-30 $97,060 23,000
2024-03-31 $91,620 18,000
2023-12-31 $167,580 18,000
2023-09-30 $119,373 18,225
2023-06-30 $146,340 18,000
2023-03-31 $154,260 18,000
2022-12-31 $166,680 18,000
2022-09-30 $185,760 18,000
2022-06-30 $180,180 18,000
2022-03-31 $221,580 18,000
2021-12-31 $316,021 18,225
2021-09-30 $327,138 18,225
2021-06-30 $416,623 18,225
2021-03-31 $272,463 18,225
2020-12-31 $98,415 18,225